SCHEMBL6575676

SCHEMBL6575676

Cc1ccc(N2CCC(C)(C)c3ccc(C#C[Si](C)(C)C)cc32)cc1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RARB P10826 6/20 0.39
RARG P13631 6/20 0.39
RARA P10276 4/20 0.39
GRM5 P41594 1/20 0.33
CYP26A1 O43174 1/20 0.32
CYP3A4 P08684 1/20 0.32
CRABP2 P29373 1/20 0.32
PIK3CA P42336 5/20 0.31
PIK3CD O00329 1/20 0.31
PIK3CB P42338 1/20 0.31
PIK3CG P48736 1/20 0.31
GABRA1 P14867 1/20 0.30
GABRG2 P18507 1/20 0.30
GABRB3 P28472 1/20 0.30
GABRA5 P31644 1/20 0.30
GABRA3 P34903 1/20 0.30
GABRA2 P47869 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8616759 0.89 RARB (0.42) RARBRARGRARAGRM5CYP26A1
SCHEMBL6574397 0.83 RARA (0.37) RARBRARGRARA
SCHEMBL6578025 0.80 RARB (0.65) RARBRARGRARACYP26A1CYP3A4
SCHEMBL8616526 0.77 RARB (0.42) RARBRARGRARAGABRA1GABRG2
SCHEMBL6576434 0.76 RARB (0.48) RARBRARGRARACYP26A1CYP3A4
SCHEMBL6578008 0.76 RARB (0.51) RARBRARGRARAGRM5CYP26A1
SCHEMBL6578064 0.76 HTR2B (0.34) CYP3A4PIK3CAGABRA1
SCHEMBL6578640 0.76 RARB (0.49) RARBRARGRARACYP26A1CYP3A4
SCHEMBL6578028 0.73 RARB (0.41) RARBRARGRARACYP26A1CYP3A4
SCHEMBL6575696 0.72 RARB (0.46) RARBRARGRARACYP26A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0937045-B1 N-ARYL SUBSTITUTED TETRAHYDROQUINOLINES LIGANDS FOR RETINOID RECEPTORS HAVING AGONIST, ANTAGONIST OR INVERSE AGONIST TYPE ACTIVITY ALLERGAN INC (US) 2004-04-28 EP disclosed
US-5739338-A SKIN DISORDERS, ANTIINFLAMMATORY AGENTS, ANTITUMOR AGENTS, VISION DEFECTS, VIRICIDES, IMMUNOSUPPRESSANTS ALLERGAN (US) 1998-04-14 US disclosed